Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma

Annals of Oncology

Volumn 8, Issue 4, 1997, Pages 401-403

  Dreger, P ^a,d   Von Neuhoff, N ^a   Kuse, R ^b   Sonnen, R ^b   Glass, B ^a   Uharek, L ^a   Bartels, H ^c   Loffler H ^a   Schmitz, N ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

^c Städtisches Krankhs Süd ^*  (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Mantle cell lymphoma; PBPC; Therapy

Indexed keywords

CARMUSTINE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADULT; ARTICLE; AUTOGRAFT; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MANTLE CELL LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; COMBINED MODALITY THERAPY; CYTARABINE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MALE; MELPHALAN; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030918133     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008251301319     Document Type: Article

References (11)

1. Meusers P, Engelhard M, Bartels H et al. Multicenter randomized therapeutical trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis. Hematol Oncol 1989; 7: 365-80.
2. Fisher I, Dahlberg S, Nathwani BN et al. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and nomocytoid B-cell subcategories): A southwest oncology group study. Blood 1995; 85: 1075-82.
3. Velders GA, Kluin-Nelemans JC, De Boer CJ et al. Mantle-cell lymphoma: A population-based clinical study. J Clin Oncol 1996; 14: 1269-74.
4. Stewart DA, Vose JM, Weisenburger DD et al. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 1995; 6: 263-6.
5. Harris NL, Jaffe ES, Stein H et al. A revised European American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
6. Stansfield A, Diebold J, Kapanci Y et al. Updated Kiel classification for lymphoma. Lancet 1988; i: 292-6.
7. Pfreundschuh M, Rueffer U, Lathan B et al. DEXA-BEAM in patients with Hodgkin's disease refractory to multi-drug regimens: A multicenter trial of the German Hodgkin's Study Group. J Clin Oncol 1994; 12: 580-6.
8. Dreger P, Klöss M, Petersen B et al. Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995; 86: 3970-8.
9. Suttorp M, von Neuhoff N, Tiemann M et al. Precast commercial polyacrylamide gels for separation of DNA amplilicates by temperature gel electrophoresis: Application to clonality analysis of lymphomas. Electrophoresis 1996; 17: 672-7.
10. Surbiguel C, Ouachee M, Sebban C et al. High dose chemotherapy in patients with mantle cell non Hodgkin'.s lymphomas. Blood 1996; 88 (Suppl 1): 568a (Abstr).
11. Provan D, Bartlett-Pandite L, Zwicky C et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 1996; 88: 2228-35.